Max C. Wygod - 15 May 2026 Form 4 Insider Report for Forian Inc. (FORA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
15 May 2026, 17:25:05 UTC
Prior SEC filing
17 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Max C. Wygod

Key filing fact

Max C. Wygod filed Form 4 for Forian Inc. (FORA) on 15 May 2026.

Key facts

  • This page summarizes Max C. Wygod's Form 4 filing for Forian Inc. (FORA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 15 May 2026, 17:25.

Change

  • Previous filing in this sequence was filed on 17 Jul 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001847923 Primary reporting owner

Wygod Max C

Relationship
Exec Chairman, CEO & President, Director, 10%+ Owner
Address
C/O FORIAN INC., 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN
Signature
/s/ Max C. Wygod
Signature date
15 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FORA transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-1,278,927
Change %
-100%
Price
Shares after
0
Date
15 May 2026
Ownership
Direct
Footnotes
F1, F2
FORA transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-250,000
Change %
-100%
Price
Shares after
0
Date
15 May 2026
Ownership
Direct
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Max C. Wygod is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

On April 2, 2026, Forian Inc., a Maryland corporation (the "Issuer"), entered into that certain Agreement and Plan of Merger (the "Merger Agreement") with 2025 Acquisition Company, LLC, a Delaware limited liability company ("Parent"), and Bravo Merger Sub, Inc., a Maryland corporation and wholly owned subsidiary of Parent ("Merger Sub"). Concurrently with the execution of the Merger Agreement, the Reporting Person and other members of a consortium entered into that certain Amendment to the Consortium Agreement, dated as of August 25, 2025, pursuant to which, among other things, the Reporting Person contributed all shares of the Issuer's common stock (the "Shares") held by the Reporting Person to Parent.

Footnote F2

On May 15, 2026, pursuant to the terms of the Merger Agreement, Parent and Merger Sub completed a tender offer for the Shares, followed by the merger of Merger Sub with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each Share held by Parent as of immediately prior to the Effective Time were cancelled without any consideration payable therefor.

Footnote F3

Represents unvested restricted stock units ("RSU").

Footnote F4

At the effective time of the Merger (the "Effective Time"), each unvested RSU or portion thereof that was outstanding as of immediately prior to the Effective Time was cancelled and converted into a right to receive an amount in cash equal to the product of (i) the total number of Shares subject to such unvested RSU immediately prior to the Effective Time multiplied by (ii) $2.17.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .